Biblio Discovery — Demo Discovery Service

196 hasil

Menampilkan 1–20 · 0,15 detik · RSS

Jurnal

Inflammatory Intestinal Diseases, Pp 1-18 (2026)

Scopus

ISSN 2296-9365 · Karger Publishers · 196 artikel di indeks

  1. Artikel Jurnal

    Case Report A Case of Elderly-Onset Ulcerative Colitis with Large-Vessel Giant Cell Arteritis Treated Successfully with Tofocitinib

    Kotaro Mitsui; Yoh Ishiguro; Naoki Higuchi dkk.

    Inflammatory Intestinal Diseases, Pp 1-18 (2026) · 2026 · Inggris · DOAJ Scopus

    Introduction: Large vessel vasculitis, including Takayasu arteritis and giant cell arteritis (GCA), is a recognized extraintestinal manifestation of ulcerative colitis (UC), but its optimal management remains unclear. GCA is the principal systemic vasculitis in individuals aged over 50 years, and…

  2. Artikel Jurnal

    Exploratory Risk Patterns of Steroid Dependency in Ulcerative Colitis: A Multicenter Pilot Study Combining Logistic Regression and Self-Organizing Map Analysis

    Yusuke Miyatani; Tetsuro Takayama; Shinji Okabayashi dkk.

    Inflammatory Intestinal Diseases, Pp 1-18 (2026) · 2026 · Inggris · DOAJ Scopus

    Introduction: Systemic corticosteroids remain widely used in ulcerative colitis (UC), yet approximately half of initial responders relapse during tapering or soon after discontinuation (steroid dependency). Understanding patients at risk of steroid dependency may inform individualized treatment…

  3. Artikel Jurnal

    CLINICAL PRESENTATION OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN: A PUZZLING STORY

    Eleanna Stasinou; Alexandra Papadopoulou

    Inflammatory Intestinal Diseases, Pp 1-12 (2026) · 2026 · Inggris · DOAJ Scopus

    Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease characterized by eosinophilic infiltration of the esophageal epithelium with esophageal dysfunction symptoms. In pediatric patients, clinical manifestations vary depending on age onset, from a gastroesophageal reflux disease…

  4. Artikel Jurnal

    A Case Study of PAMI Syndrome Masquerading as Inflammatory Bowel Disease

    Pongsawat Rodsaward; Keerati Kiattikunrat; Nichthida Tangnuntachai dkk.

    Inflammatory Intestinal Diseases, Pp 1-14 (2026) · 2026 · Inggris · DOAJ Scopus

    Introduction: PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome is a rare autoinflammatory disorder. Systemic inflammation, cytopenia, and skin lesions are classic features, accompanied by hypercalprotectinemia and hyperzincemia. Gastrointestinal manifestations such as…

  5. Artikel Jurnal

    Balloon-assisted Enteroscopy Assesses Endoscopic Remission and Mucosal Healing Following Risankizumab Initiation in Crohn’s Disease

    Shinya Yoshida; Atsushi Nishida; Yoshihiro Yokota dkk.

    Inflammatory Intestinal Diseases, Pp 1-19 (2026) · 2026 · Inggris · DOAJ Scopus

    Background: Endoscopic control of inflammation is a key treatment goal in Crohn’s disease. However, real-world endoscopic outcomes of risankizumab assessed by paired balloon-assisted enteroscopy remain limited. We examined endoscopic outcomes at the visit closest to week 52 after risankizumab…

  6. Artikel Jurnal

    Upadacitinib Treatment Outcomes in Crohn’s Disease: A Retrospective Analysis of Clinical Response and Perianal Fistula Resolution

    Junya Shiota; Moto Kitayama; Hiroko Inomata dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Upadacitinib (UPA), a Janus kinase inhibitor approved for the treatment of Crohn’s disease (CD), has demonstrated high efficacy in clinical trials; however, real-world data on its outcomes remain limited. This study evaluated UPA outcomes in patients with CD in a real-world setting…

  7. Artikel Jurnal

    Individual Variations in Anti-αvβ6 Autoantibody Levels Determined by <italic>ITGAV</italic> Gene Polymorphisms: Associations with Genetic Background and Relapse in Ulcerative Colitis

    Satoshi Ono; Yoshiharu Yamaguchi; Akane Sugimura dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Increased expression of the epithelial-specific adhesion molecule integrin αvβ6 and the presence of anti-αvβ6 autoantibodies (V6 Ab) have been reported in ulcerative colitis (UC). However, the influence of single-nucleotide polymorphisms (SNPs) in the ITGAV gene on antibody titers, as…

  8. Artikel Jurnal

    Real-World Adherence and Relapse Risk in Mesalamine Treatment for Ulcerative Colitis: Insights from a Large Japanese Medical Claims Database

    Takafumi Wada; Shuhei Hosomi; Yumie Kobayashi dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: 5-Aminosalicylic acid (5-ASA, mesalamine) is the cornerstone for maintaining remission in mild-to-moderate ulcerative colitis (UC), with several formulations available. Nonadherence to mesalamine is associated with increased relapse risk; however, large-scale real-world data comparing…

  9. Artikel Jurnal

    The Role of B Cells and Antibodies in Eosinophilic Esophagitis

    Manal Bel Imam; Hang Du; Özge Ardicli dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background: Eosinophilic esophagitis (EoE) is a chronic, immune-mediated inflammatory disease affecting the esophagus, characterized by esophageal dysfunction, dysphagia, and tissue remodeling, leading to significant impairment in quality of life. The pathogenesis of EoE involves a complex…

  10. Artikel Jurnal

    Effectiveness of Intravenous Corticosteroid in Patients with Ulcerative Colitis after Oral Corticosteroid Failure: Differences by Prior Response to Oral Therapy in a Multicenter Cohort Study

    Tomohiro Fukuda; Kenji Tatsumi; Naoko Inagaki dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Moderate-to-severe ulcerative colitis (UC) is commonly treated with oral corticosteroids. However, in cases of oral corticosteroid failure, no clear consensus exists on whether to transition to intravenous corticosteroids (IVCS) or initiate advanced therapies. The aim of this study…

  11. Artikel Jurnal

    Extraintestinal Manifestations and Cytomegalovirus Reactivation Are Predictors of Difficult-To-Treat in Ulcerative Colitis

    Kotaro Akita; Mayuko Erata; Yoshihiro Yokoyama dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Ulcerative colitis (UC) is a diffuse, nonspecific inflammatory disease of unknown etiology. Although corticosteroids are essential for inducing remission in moderate to severe UC, steroid dependence and refractoriness remain significant clinical obstacles. Predicting which patients…

  12. Artikel Jurnal

    Real-World Efficacy of Ustekinumab versus Vedolizumab for Ulcerative Colitis: Differences between Short- and Long-Term Outcomes Based on Endoscopic Remission

    Makoto Furuya; Jun Kato; Ken Takeuchi dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Ustekinumab (UST) and vedolizumab (VED) are effective for ulcerative colitis (UC), but long-term real-world data, particularly regarding endoscopic remission, remain limited. Methods: Patients with UC who were treated with UST or VED at two tertiary centers were enrolled in this…

  13. Artikel Jurnal

    Intestinal Endometriosis Mimicking Ulcerative Colitis-Associated Neoplasia: A Case Report

    Ke Han; Hiroki Kiyohara; Shinya Sugimoto dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Intestinal endometriosis is a benign condition characterized by the presence of endometrial tissue within the bowel wall, often mimicking colorectal malignancy. Its coexistence with ulcerative colitis (UC) is rare and can complicate the diagnosis. Case Presentation: A 35-year-old…

  14. Artikel Jurnal

    Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein Levels in Inflammatory Bowel Disease Patients across Racial Groups

    Yasuhiro Aoki; Hiroki Kiyohara; Shinya Sugimoto dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Serum leucine-rich alpha-2 glycoprotein (LRG) has emerged as a novel biomarker for inflammatory bowel disease (IBD). However, its clinical utility among non-Japanese populations has not been investigated. This study aimed to validate the diagnostic ability of serum LRG in non-Japanese…

  15. Artikel Jurnal

    Upadacitinib versus Tofacitinib in the Management of Ulcerative Colitis: A Systematic Review and Meta-Analysis

    Tareq Alsaleh; Abdul Mohammed; Aimen Farooq dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Upadacitinib and tofacitinib, oral Janus kinase inhibitors, have demonstrated efficacy and safety in ulcerative colitis (UC) in clinical trials. However, real-world comparative data are limited. We conducted a systematic review and meta-analysis of studies directly comparing…

  16. Artikel Jurnal

    Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn’s Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix Cohort

    Shinsuke Otagiri; Keiya Aoyama; Takehiko Katsurada dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Real-world data on the long-term effectiveness of vedolizumab (VDZ) in East Asian patients with Crohn’s disease (CD) remain limited. This study aimed to assess treatment persistence, clinical and endoscopic effectiveness, safety, and predictors of VDZ discontinuation in a multicenter…

  17. Artikel Jurnal

    Leucine-Rich Alpha-2 Glycoprotein Is an Accurate Serum Marker for Endoscopic and Histological Remission in Ulcerative Colitis

    Ami Kawamoto; Toshimitsu Fujii; Shohei Tanaka dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Achieving both endoscopic and histological remission in ulcerative colitis (UC) is associated with improved clinical outcomes. There is a growing need for noninvasive methods to assess both remission states. This study investigates the utility of serum leucine-rich alpha-2…

  18. Artikel Jurnal

    Emu Oil: A Potential Adjunct to Inflammatory Bowel Disease Treatment?

    Sisanda Nomcebo Mhlanga; Gordon Stanley Howarth; Suzanne Mashtoub

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background: Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic lifelong condition that affects the colon to a variable extent. Current treatments for IBD include aminosalicylate-based drugs, corticosteroids, antibiotics, immunomodulators, biologics…

  19. Artikel Jurnal

    Challenges in the Diagnosis of Eosinophilic Colitis: Insights from Cases Initially Diagnosed as Inflammatory Bowel Disease

    Natsuki Sumiyoshi; Takahiko Toyonaga; Miku Maeda dkk.

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction: Eosinophilic colitis (EoC) is an immune-mediated disorder characterized by chronic colitis with significant eosinophilic infiltration. Diagnosing EoC is sometimes challenging due to more common disorders associated with colonic eosinophilia like inflammatory bowel disease (IBD). This…

  20. Artikel Jurnal

    Unmet Needs in Eosinophilic Esophagitis: Do We Still Have Some?

    Amiko M. Uchida; Kathryn Peterson

    Inflammatory Intestinal Diseases, Vol. 11 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background: Since the late 1990s, eosinophilic esophagitis (EoE) became a known disease characterized by eosinophilic infiltration into the esophagus accompanied by esophageal symptoms. Over the past 2 decades, there has been an exponential increase in the understanding of the epidemiology and…